Taylor Hoffman Capital Management LLC bought a new stake in Albemarle Co. (NYSE:ALB – Free Report) during the 4th quarter, HoldingsChannel reports. The fund bought 14,034 shares of the specialty chemicals company’s stock, valued at approximately $1,208,000.
Several other hedge funds and other institutional investors have also made changes to their positions in ALB. Manning & Napier Advisors LLC purchased a new stake in shares of Albemarle in the fourth quarter valued at $85,570,000. Norges Bank purchased a new stake in shares of Albemarle in the fourth quarter valued at $39,405,000. Vanguard Group Inc. increased its stake in Albemarle by 2.5% in the 4th quarter. Vanguard Group Inc. now owns 14,594,499 shares of the specialty chemicals company’s stock worth $1,256,294,000 after buying an additional 359,014 shares during the period. Pictet Asset Management Holding SA increased its stake in Albemarle by 36.7% in the 4th quarter. Pictet Asset Management Holding SA now owns 1,192,527 shares of the specialty chemicals company’s stock worth $102,653,000 after buying an additional 320,150 shares during the period. Finally, Man Group plc increased its stake in Albemarle by 1,213.0% in the 4th quarter. Man Group plc now owns 158,649 shares of the specialty chemicals company’s stock worth $13,657,000 after buying an additional 146,566 shares during the period. Hedge funds and other institutional investors own 92.87% of the company’s stock.
Analyst Ratings Changes
ALB has been the topic of several recent analyst reports. TD Securities reduced their price target on shares of Albemarle from $115.00 to $65.00 and set a “hold” rating on the stock in a research note on Thursday, May 1st. Wells Fargo & Company lowered their price target on shares of Albemarle from $80.00 to $60.00 and set an “equal weight” rating on the stock in a report on Wednesday, April 9th. StockNews.com upgraded shares of Albemarle to a “sell” rating in a research note on Monday, May 5th. Morgan Stanley lowered their target price on shares of Albemarle from $68.00 to $58.00 and set an “underweight” rating for the company in a research note on Tuesday, May 6th. Finally, Truist Financial lowered their target price on shares of Albemarle from $85.00 to $65.00 and set a “hold” rating for the company in a research note on Monday, April 14th. Three research analysts have rated the stock with a sell rating, fourteen have assigned a hold rating and five have assigned a buy rating to the stock. According to MarketBeat.com, the company has a consensus rating of “Hold” and an average target price of $91.62.
Albemarle Price Performance
NYSE:ALB opened at $59.34 on Wednesday. The company has a debt-to-equity ratio of 0.39, a current ratio of 1.95 and a quick ratio of 1.19. The firm has a market cap of $6.98 billion, a price-to-earnings ratio of -5.30 and a beta of 1.71. The company has a 50 day moving average price of $62.67 and a 200-day moving average price of $81.17. Albemarle Co. has a 1-year low of $49.43 and a 1-year high of $130.80.
Albemarle (NYSE:ALB – Get Free Report) last released its quarterly earnings results on Wednesday, April 30th. The specialty chemicals company reported ($0.18) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.62) by $0.44. Albemarle had a negative net margin of 21.93% and a negative return on equity of 1.72%. The firm had revenue of $1.08 billion for the quarter, compared to analysts’ expectations of $1.18 billion. During the same quarter last year, the company earned $0.26 EPS. The firm’s revenue for the quarter was down 20.9% compared to the same quarter last year. Equities research analysts forecast that Albemarle Co. will post -0.04 EPS for the current year.
Albemarle Announces Dividend
The business also recently declared a quarterly dividend, which will be paid on Tuesday, July 1st. Investors of record on Friday, June 13th will be paid a $0.405 dividend. The ex-dividend date of this dividend is Friday, June 13th. This represents a $1.62 dividend on an annualized basis and a yield of 2.73%. Albemarle’s dividend payout ratio is currently -14.57%.
Albemarle Profile
Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. It operates through three segments: Energy Storage, Specialties and Ketjen. The Energy Storage segment offers lithium compounds, including lithium carbonate, lithium hydroxide, and lithium chloride; technical services for the handling and use of reactive lithium products; and lithium-containing by-products recycling services.
See Also
- Five stocks we like better than Albemarle
- How is Compound Interest Calculated?
- Qualcomm’s Re-Entry Into the CPU Market May Not Be Enough
- How to Invest in the Best Canadian StocksÂ
- Applied Digital’s Strategic AI Play Gains Momentum
- What is a Microcap Stock? Everything You Need to Know
- Top 5 Stocks Hedge Funds Are Buying Right Now
Want to see what other hedge funds are holding ALB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Albemarle Co. (NYSE:ALB – Free Report).
Receive News & Ratings for Albemarle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Albemarle and related companies with MarketBeat.com's FREE daily email newsletter.